口腔鳞状细胞癌治疗研究进展  

Research progress in the treatment of oral squamous cell carcinoma

作　　者：张静[1] 张敏[1] 路平[1] ZHANG Jing;ZHANG Min;LU Ping(Ward Ⅱ,Department of Oncology,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)

机构地区：[1]新乡医学院第一附属医院肿瘤内科二病区,河南卫辉453100

出　　处：《新乡医学院学报》2024年第2期180-186,共7页Journal of Xinxiang Medical University

基　　金：2020年新乡医学院第一临床学院研究生科研创新支持计划资助项目(编号:YJSCX202046Y)。

摘　　要：口腔鳞状细胞癌(OSCC)是最常见的一种头颈部肿瘤,其发病隐匿,易发生转移,5 a生存期短,病死率高。目前,OSCC治疗的方法多种多样,但均不可避免地导致与非特异性细胞死亡相关的问题;因此,迫切需要为OSCC寻找其他新的治疗方案。本文就OSCC治疗的研究进展进行综述,以期为临床OSCC的治疗提供新的选择。Oral squamous cell carcinoma(OSCC),the most common type of head and neck tumor,is characterized by insidious onset,susceptibility to metastasis,short 5-year survival,and high mortality rate.Currently,various treatment modalities exist for OSCC;however,they inevitably give rise to issues related to non-specific cell death.Therefore,there is an urgent need to explore alternative therapeutic approaches for OSCC.This article provides a comprehensive overview of the recent advancements in OSCC treatment,aiming to offer new avenues for future therapeutic strategies.

关 键 词：口腔鳞状细胞癌 靶向治疗 免疫治疗 血管内皮生长因子 

分 类 号：R739.8[医药卫生—肿瘤]